Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Accepts healthy volunteers

Dopamine Function and Reward Processing In Schizophrenia

ClinicalTrials.gov ID: NCT01035996

Public ClinicalTrials.gov record NCT01035996. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 8, 2026, 10:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Background: \- Schizophrenia is associated with cognitive impairment in different parts of the brain, including those associated with learning and memory. The brain activity associated with these impairments, however, is poorly understood. Researchers are interested in studying how the brain chemical dopamine, which is involved in responding to incentives and rewards like money or food, works differently in the brains of people who have schizophrenia. Objectives: \- To study reward processing in individuals with schizophrenia who are taking different types of medication, compared with healthy volunteers. Eligibility: \- Individuals between 18 and 55 years of age who (a) have been diagnosed with schizophrenia/schizoaffective disorder and are taking the antipsychotic medication clozapine, (b), have been diagnosed with schizophrenia/schizoaffective disorder and are taking a different second-generation antipsychotic, or (c) are healthy volunteers. Design: * This study will involve one screening visit and one or more visits for testing and functional magnetic resonance imaging (fMRI) scans. During the screening visit, participants will complete questionnaires and provide information about their physical and psychological health. * Participants will receive training in the tasks to be performed at the scanning sessions during the screening visit. * During the fMRI scans, participants will complete one or two of four possible reward-based tasks: * A task that enables participants to win money based on their response to a target item. * A task that provides small amounts of juice over specific time intervals, followed by a procedure to be completed outside the scanner. * A task that involves choosing figures or shapes and winning money based on responses. * A game of chance involving predictions based on shapes shown on a screen. * Participants will also provide blood samples for research and testing.

Study identification

NCT ID
NCT01035996
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
159 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 7, 2005
Primary completion
Not listed
Completion
Feb 12, 2017
Last update posted
Dec 8, 2019

2005 – 2017

United States locations

U.S. sites
2
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
University of Maryland, Baltimore Baltimore Maryland 21201-1595
National Institute on Drug Abuse, Biomedical Research Center (BRC) Baltimore Maryland 21224

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01035996, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 8, 2019 · Synced Sep 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01035996 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →